BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15743491)

  • 1. Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.
    Wahl SM; Chen W
    Arthritis Res Ther; 2005; 7(2):62-8. PubMed ID: 15743491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
    J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cell-mediated suppression of autoimmunity in a murine lupus model of peptide-induced immune tolerance depends on Foxp3 expression.
    Singh RP; La Cava A; Wong M; Ebling F; Hahn BH
    J Immunol; 2007 Jun; 178(12):7649-57. PubMed ID: 17548601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
    Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
    Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
    Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
    Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
    J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuning immune suppression in systemic autoimmunity with self-derived peptides.
    Singh RP; Hahn BH; La Cava A
    Inflamm Allergy Drug Targets; 2008 Dec; 7(4):253-9. PubMed ID: 19075790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
    Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
    PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells.
    Prochazkova J; Fric J; Pokorna K; Neuwirth A; Krulova M; Zajicova A; Holan V
    Immunology; 2009 Sep; 128(1 Suppl):e670-8. PubMed ID: 19740328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
    Qiao M; Thornton AM; Shevach EM
    Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TGF-Beta in the induction of Foxp3 expression and T regulatory cell function.
    Shevach EM; Davidson TS; Huter EN; Dipaolo RA; Andersson J
    J Clin Immunol; 2008 Nov; 28(6):640-6. PubMed ID: 18810612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
    Sharabi A; Mozes E
    J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
    Skapenko A; Kalden JR; Lipsky PE; Schulze-Koops H
    J Immunol; 2005 Nov; 175(9):6107-16. PubMed ID: 16237107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
    Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
    J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
    Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
    Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.